Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01830712 · ClinicalTrials.gov registry record
A Long-term Assessment of Physical Activity, Range of Motion, and Functional Status Following Elective Orthopedic Surgery in Hemophilia Patients With Inhibitors
A clinical trial, sponsored by Novo Nordisk A/S.
- Completed
- Registry status
- 15
- Enrollment target
NCT01830712 is a clinical trial that has completed, run by Novo Nordisk A/S. The registered enrollment target is 15 participants.
The verdict
NCT01830712 has completed, sponsored by Novo Nordisk A/S.
- COMPLETED
- Registry status
- 15 participants
- Enrollment target
Study Summary
This study is conducted in the United States of America (USA). The aim of this study is to assess the long-term (5+ years) postoperative functional outcomes of elective orthopaedic surgery (EOS) patients from previously reported studies F7HAEM/USA/3/USA and F7HAEM/USA/4/USA (NCT01561391) and furthermore to assess the impact of EOS on psychosocial outcomes, frequency of bleeding episodes and durability of joint surgery.
Interventions
- DRUG eptacog alfa (activated)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2011-04 |
| Est. Completion | 2011-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01830712
The ClinicalTrials.gov registry entry for NCT01830712 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Novo Nordisk A/S, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which eptacog alfa (activated) is the first listed.
NCT01830712 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01830712 about?
NCT01830712 is a clinical study titled "A Long-term Assessment of Physical Activity, Range of Motion, and Functional Status Following Elective Orthopedic Surgery in Hemophilia Patients With Inhibitors". This study is conducted in the United States of America (USA). The aim of this study is to assess the long-term (5+ years) postoperative functional outcomes of elective orthopaedic surgery (EOS) patients from previously reported studies F7HAEM/USA/3/USA and F7HAEM/USA/4/USA (NCT01561391) and further...
What is the current status of trial NCT01830712?
This trial is currently completed. The enrollment target is 15 participants. The study started on 2011-04. Estimated completion is 2011-08.
What interventions are being tested in trial NCT01830712?
The interventions under investigation include: eptacog alfa (activated) (DRUG).
Who is sponsoring clinical trial NCT01830712?
This trial is sponsored by Novo Nordisk A/S, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.